Tamara Darsow, PhD
Global Vice President, Global Business Development
Novo Nordisk
Tamara Darsow is a pharmaceutical executive dedicated to improving the health and well-being of people living with chronic cardiometabolic diseases. With more than 20 years of experience in the pharmaceutical and life sciences sectors, she has a proven track record of identifying innovation, cultivating high-value partnerships, and accelerating the development of differentiated medicines that drive market expansion.
Tamara has held leadership positions at Novo Nordisk over the last 8 years across Research and Development, Commercial and Corporate Strategy. Currently, as Global Vice President of Global Business Development, she plays a pivotal role in shaping the company's strategic growth by leading its M&A, BD&L and partnership initiatives. She works across academic, biotech and large pharmaceutical organizations and has been instrumental in closing critical deals in multiple therapy areas, including diabetes, obesity and cardiometabolic disease.
Prior to joining Novo Nordisk, Tamara held leadership positions at the American Diabetes Association and Amylin Pharmaceuticals and obtained a PhD from UCSD prior to being a Damon Runyon postdoctoral fellow at The Salk Institute for Biological Studies in neuroscience.
Sessions
-
24-Jun-202628ABCDEFireside Chat: Novo Nordisk + Akero: Behind the Scenes of a Landmark Deal
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}